Serono Pergonal production to be sharply reduced as purified Metrodin production increases.
SERONO PERGONAL PRODUCTION WILL BE REDUCED AS PURIFIED METRODIN is produced in increasing quantities, Serono said while discussing the shortage of the two fertility drugs ("The Pink Sheet" Feb. 27, In Brief). A "highly purified urinary-derived formulation" of follicle stimulating hormone "has already achieved wide and rapid acceptance in many markets throughout the world, replacing cruder gonadotropins such as Metrodin and Pergonal," Serono said.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth